Cisplatin + Etoposide for Lung Cancer - ChemoExperts
网页Cisplatin + Etoposide are designed to kill cancer cells by damaging DNA and preventing the lung cancer cells from dividing into new cells. Cisplatin + Etoposide is commonly given with the goal of cure, however small cell lung cancer frequently relapses, and further therapy may be offered if this occurs.
Etoposide and cisplatin chemotherapy (EP) - Macmillan Cancer …
网页Etoposide and cisplatin chemotherapy, known as EP (or sometimes PE), is used to treat several types of cancer. Learn more about it.
Four Cycles of Etoposide plus Cisplatin for Patients with …
网页2021年3月12日 · The NCCN recommends either three cycles of bleomycin, etoposide, and cisplatin (BEPx3) or four cycles of etoposide and cisplatin (EPx4) as initial chemotherapy for the treatment of good‐risk germ cell tumors. This article assesses outcomes specific to EPx4 treatment.
Etoposide plus cisplatin chemotherapy improves the efficacy and …
网页2021年11月15日 · This study is designed to evaluate the efficacy and safety of etoposide plus platinum in the treatment of SCLC. Methods: A retrospective analysis was performed on 112 patients with SCLC admitted to the China-Japan Union Hospital of Jilin University from 2016 to 2018.
Treatment protocols for small-cell carcinoma of the lung
网页2022年10月21日 · INTRODUCTION. The following material represents a subset of chemotherapy and immunotherapy regimens that are used for the treatment of patients with small-cell carcinoma of the lung.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage …
网页2018年9月25日 · Standard-of-care first-line treatment for extensive-stage small-cell lung cancer is platinum chemotherapy (carboplatin or cisplatin) with etoposide. 1-3 Despite response rates of 60 to 65%,...
Etoposide - StatPearls - NCBI Bookshelf
网页2023年7月4日 · As part of the bleomycin, etoposide, cisplatin (BEP) therapy, etoposide has been proven effective for metastatic non-seminomatous testicular cancer and malignant ovarian germ cell tumors.
Four Cycles of Etoposide plus Cisplatin for Patients with Good …
网页Four cycles of etoposide and cisplatin (EPx4) is a standard-of-care regimen for all patients with good-risk germ cell tumors with a favorable response rate and disease-specific survival of 98%. Full-dose administration of etoposide and cisplatin and complete resection of residual disease lead to opt ….
Durvalumab plus platinum–etoposide versus platinum–etoposide …
网页2019年11月23日 · Recently, immunotherapy has demonstrated clinical activity in extensive-stage SCLC (ES-SCLC). The CASPIAN trial assessed durvalumab, with or without tremelimumab, in combination with etoposide plus either cisplatin or carboplatin (platinum–etoposide) in treatment-naive patients with ES-SCLC.
Carboplatin versus cisplatin in combination with etoposide in …
网页2021年12月7日 · In this study, we compared the efficacy and safety between the cisplatin plus etoposide (EP) and carboplatin plus etoposide (EC) regimens. A total of 1305 patients with previously untreated ES-SCLC were included in this study.